Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Trabectedin × 1 year × Clear all

Sponsor

Conditions

Sarcoma 7 Solitary Fibrous Tumors 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Recurrent High Grade Meningioma 1 Recurrence 1 Ovarian Neoplasms 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leiomyosarcoma Uterus 1 Histiocytoma, Malignant Fibrous 1 Hemangioendothelioma 1

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡